TriangleVenetoclax (NCT03214562)
Venetoclax trial for Acute Myeloid Leukemia (NCT03214562). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
Lo que dice el vídeo
Lee la transcripción
This trial is for acute myeloid leukemia, newly diagnosed or one that has come back.
The idea: add a targeted pill to standard intensive chemotherapy. The pill, venetoclax, blocks a protein called BCL-2. It is taken by mouth for part of each cycle, alongside a chemotherapy regimen called FLAG-IDA.
In a published report of 138 patients, 95 percent of newly diagnosed patients reached remission. Infections and low blood counts were common. It was a single group, with no comparison. At MD Anderson in Houston, Courtney DiNardo leads the study.
Public record; not medical advice.
¿Ya estás en un ensayo?
Se convierte en un proyecto que hay que manejar: citas, estudios de imagen, análisis, efectos secundarios y papeleo. Triangle lo mantiene organizado en un solo lugar, para ti o para quien te ayuda.
Organizar mi ensayoPrueba gratuita de 7 días, después $9 al mes. Cancela cuando quieras.
Cómo funcionan estos ensayos: qué es de verdad la fase 1 · preguntas frecuentes No es evidencia clínica.